MDs' One-Word Summary of Long COVID Progress: 'Frustration'

Researchers and clinicians now have a greater understanding of what health agencies formally call post-COVID condition, but the wide spectrum of symptoms, slow progress in launching pharmacologic clinical trials, and the research toward understanding the underlying causes mean standardized diagnostic tests and definitive treatments remain elusive. This piece follows a doctor and his patient as they navigate the complexities and challenges around long COVID. Read the full story on Medscape.

‘Snake Oil’ Fake Cures for Long COVID Leave Patients at Risk

From fad diets and vitamins to “blood washing” and stem cell therapy, long COVID patients are seeking out experimental therapies in a desperate bid to find hope and relief from debilitating symptoms. But doctors worry about the potential harm – both physical and financial – some of these unproven and overhyped treatments could cause.

Long COVID Could Cost the Economy Trillions, Experts Predict

Staffing challenges across multiple industries have been attributed in part to the "great resignation" and in part because so many infected workers were out, especially during the Omicron waves. But increasingly, economists and health care professionals alike worry about long COVID's impact on employers and the broader economy.